Cardiovascular and metabolic acute effects of heated tobacco products in healthy smokers.

Authors

Lea Strohm, Dominika Mihaliková, Alexander Czarnowski, Patrick Dittmann, Dominik Gillenkirch, Omar Hahad, Michael Molitor, Marin Kuntic, Philipp Lurz, Thomas Münzel, Andreas Daiber, Paul Stamm

Published in

European journal of preventive cardiology. Oct 27, 2026. Epub Oct 27, 2026.

Abstract

Heated tobacco products (HTPs) are increasingly promoted as 'reduced-harm' alternatives to combustible cigarettes, despite delivering pharmacologically active nicotine and complex aerosols. Independent human data on their acute cardiovascular effects remain limited.
In this investigator-initiated, within-subject pre-post study, healthy adult smokers were supervised in their exposure to two consecutive HTP sticks (IQOS). Endothelial function was assessed by brachial artery flow-mediated dilation (FMD), along with haemodynamic parameters, venous blood gas and metabolic markers, and oxidative DNA damage measured by the comet assay. Acute HTP exposure resulted in a significant reduction in FMD, indicating rapid endothelial dysfunction. This was accompanied by an increase in systolic blood pressure, reductions in venous oxygen tension and saturation, and an increase in venous carbon dioxide, consistent with impaired tissue oxygenation. Methaemoglobin levels increased, reflecting oxidative modification of haemoglobin, while metabolic alterations in glucose and lactate suggested nicotine-mediated sympathetic and metabolic stress. Importantly, short-term HTP use induced significant oxidative DNA damage in peripheral blood cells. These effects occurred after a single, real-world exposure in otherwise healthy smokers.
Together, these findings demonstrate that HTPs are not biologically inert and that acute exposure is sufficient to trigger vascular dysfunction, systemic metabolic disturbance, and genotoxic stress. The results challenge claims of cardiovascular harm reduction and underscore that all nicotine-containing products remain relevant targets for cardiovascular prevention and regulation.

PMID:
42935009
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.